|
| 37917186 | The murine metastatic microenvironment of experimental brain metastases of breast cancer differs by host age in vivo: a proteomic study. | Clin Exp Metastasis | 2024 |
| 36905875 | Fear of recurrence, emotional well-being and quality of life among long-term advanced ovarian cancer survivors. | Gynecol Oncol | 2023 |
| 38057616 | Deep learning-based segmentation of multisite disease in ovarian cancer. | Eur Radiol Exp | 2023 |
| 37838706 | Automated imaging and identification of proteoforms directly from ovarian cancer tissue. | Nat Commun | 2023 |
| 37833300 | Brain proteomic atlas of alcohol use disorder in adult males. | Transl Psychiatry | 2023 |
| 38040721 | Author Correction: Automated imaging and identification of proteoforms directly from ovarian cancer tissue. | Nat Commun | 2023 |
| 37923835 | In situ profiling reveals metabolic alterations in the tumor microenvironment of ovarian cancer after chemotherapy. | NPJ Precis Oncol | 2023 |
| 37639904 | Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatment. | Gynecol Oncol | 2023 |
| 37255276 | Integration of Multi-omic Data in a Molecular Tumor Board Reveals EGFR-Associated ALK-Inhibitor Resistance in a Patient With Inflammatory Myofibroblastic Cancer. | Oncologist | 2023 |
| 37067801 | Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine Cancer. | JAMA Netw Open | 2023 |
| 36849657 | Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer. | Nat Genet | 2023 |
| 36572991 | CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. | Cancer | 2023 |
| 34782936 | MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma. | Virchows Arch | 2022 |
| 35654359 | New Views of Old Proteins: Clarifying the Enigmatic Proteome. | Mol Cell Proteomics | 2022 |
| 35406738 | CARD19 Interacts with Mitochondrial Contact Site and Cristae Organizing System Constituent Proteins and Regulates Cristae Morphology. | Cells | 2022 |
| 35723500 | Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment. | J Vis Exp | 2022 |
| 35625955 | Whole-Genome Sequencing Identifies <i>PPARGC1A</i> as a Putative Modifier of Cancer Risk in <i>BRCA1/2</i> Mutation Carriers. | Cancers (Basel) | 2022 |
| 35624045 | Conditional estimates for uterine serous cancer: Tools for survivorship counseling and planning. | Gynecol Oncol | 2022 |
| 36456881 | The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer. | Nat Genet | 2022 |
| 36528667 | Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors. | J Transl Med | 2022 |
| 35940219 | Expression of CYP450 enzymes in human fetal membranes and its implications in xenobiotic metabolism during pregnancy. | Life Sci | 2022 |
| 36239936 | Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics. | JAMA Netw Open | 2022 |
| 36384096 | Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways. | Cell Rep Med | 2022 |
| 36195845 | Proteomic alterations associated with residual disease in neoadjuvant chemotherapy treated ovarian cancer tissues. | Clin Proteomics | 2022 |
| 36077609 | Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study. | Cancers (Basel) | 2022 |
| 35326647 | Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian Cancer. | Cancers (Basel) | 2022 |
| 33190933 | Evaluation of publicly available in vitro drug sensitivity models for ovarian and uterine cancer. | Gynecol Oncol | 2021 |
| 33563487 | Clinical significance of homologous recombination deficiency score testing in endometrial Cancer. | Gynecol Oncol | 2021 |
| 33729494 | Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer Survival. | J Natl Cancer Inst | 2021 |
| 33931688 | Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patients. | Sci Rep | 2021 |
| 35036865 | Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry. | iScience | 2021 |
| 34615962 | Proteomics analysis identifies PEA-15 as an endosomal phosphoprotein that regulates α5β1 integrin endocytosis. | Sci Rep | 2021 |
| 34404802 | ELMO1 signaling is a promoter of osteoclast function and bone loss. | Nat Commun | 2021 |
| 34538531 | Obesity and altered angiogenic-related gene expression in endometrial cancer. | Gynecol Oncol | 2021 |
| 34301959 | Deacetylation as a receptor-regulated direct activation switch for pannexin channels. | Nat Commun | 2021 |
| 34278265 | Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens. | iScience | 2021 |
| 32253542 | Integration of proteomics with CT-based qualitative and radiomic features in high-grade serous ovarian cancer patients: an exploratory analysis. | Eur Radiol | 2020 |
| 32029291 | Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival. | Gynecol Oncol | 2020 |
| 31808620 | Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers. | Cancer Med | 2020 |
| 33067419 | Standardization and harmonization of distributed multi-center proteotype analysis supporting precision medicine studies. | Nat Commun | 2020 |
| 32165870 | The impact of ultraviolet- and infrared-based laser microdissection technology on phosphoprotein detection in the laser microdissection-reverse phase protein array workflow. | Clin Proteomics | 2020 |
| 32294438 | Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer. | Cell Rep | 2020 |
| 30643265 | A noncanonical role for the engulfment gene ELMO1 in neutrophils that promotes inflammatory arthritis. | Nat Immunol | 2019 |
| 30110125 | CYPOR is a novel and independent prognostic biomarker of recurrence-free survival in triple-negative breast cancer patients. | Int J Cancer | 2019 |
| 31242424 | Increased Cholesterol Biosynthesis Is a Key Characteristic of Breast Cancer Stem Cells Influencing Patient Outcome. | Cell Rep | 2019 |
| 31517012 | Sixteen year-old with leiomyosarcoma in a prior benign myomectomy site. | Gynecol Oncol Rep | 2019 |
| 31371750 | Prospective Validation of an Ex Vivo, Patient-Derived 3D Spheroid Model for Response Predictions in Newly Diagnosed Ovarian Cancer. | Sci Rep | 2019 |
| 31279844 | Biomarker panel for early detection of endometrial cancer in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial. | Am J Obstet Gynecol | 2019 |
| 31221207 | Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer. | J Immunother Cancer | 2019 |
| 31274231 | Final analysis of a phase I/IIa trial of the folate-binding protein-derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients. | Cancer Med | 2019 |